journal article Open Access Apr 14, 2021

Update on Coagulase-Negative Staphylococci—What the Clinician Should Know

Microorganisms Vol. 9 No. 4 pp. 830 · MDPI AG
View at Publisher Save 10.3390/microorganisms9040830
Abstract
Coagulase-negative staphylococci (CoNS) are among the most frequently recovered bacteria in routine clinical care. Their incidence has steadily increased over the past decades in parallel to the advancement in medicine, especially in regard to the utilization of foreign body devices. Many new species have been described within the past years, while clinical information to most of those species is still sparse. In addition, interspecies differences that render some species more virulent than others have to be taken into account. The distinct populations in which CoNS infections play a prominent role are preterm neonates, patients with implanted medical devices, immunodeficient patients, and those with other relevant comorbidities. Due to the property of CoNS to colonize the human skin, contamination of blood cultures or other samples occurs frequently. Hence, the main diagnostic hurdle is to correctly identify the cases in which CoNS are causative agents rather than contaminants. However, neither phenotypic nor genetic tools have been able to provide a satisfying solution to this problem. Another dilemma of CoNS in clinical practice pertains to their extensive antimicrobial resistance profile, especially in healthcare settings. Therefore, true infections caused by CoNS most often necessitate the use of second-line antimicrobial drugs.
Topics

No keywords indexed for this article. Browse by subject →

References
99
[1]
Emergence of coagulase-negative staphylococci

Karsten Becker, Anna Both, Samira Weißelberg et al.

Expert Review of Anti-infective Therapy 2020 10.1080/14787210.2020.1730813
[2]
Pain, M., Wolden, R., Jaén-Luchoro, D., Salvà-Serra, F., Iglesias, B.P., Karlsson, R., Klingenberg, C., and Cavanagh, J.P. (2020). Staphylococcus borealis sp. nov., isolated from human skin and blood. Int. J. Syst. Evol. Microbiol., 70. 10.1099/ijsem.0.004499
[3]
Becker "Implications of identifying the recently defined members of the Staphylococcus aureus complex S. argenteus and S. schweitzeri: A position paper of members of the ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS)" Clin. Microbiol. Infect. (2019) 10.1016/j.cmi.2019.02.028
[4]
Alhussein "Human infections caused by Staphylococcus argenteus in Germany: Genetic characterisation and clinical implications of novel species designation" Eur. J. Clin. Microbiol. Infect. Dis. (2020) 10.1007/s10096-020-03950-4
[5]
Nurjadi "Nasal colonization with Staphylococcus aureus is a risk factor for ventricular assist device infection in the first year after implantation: A prospective, single-centre, cohort study" J. Infect. (2020) 10.1016/j.jinf.2020.02.015
[6]
Aldman, M.H., Rasmussen, M., Olaison, L., and Påhlman, L.I. (2020). Endocarditis due to Staphylococcus lugdunensis—A retrospective national registry-based study. Eur. J. Clin. Microbiol. Infect. Dis. 10.1007/s10096-020-04134-w
[7]
Hussain, M., Kohler, C., and Becker, K. (2020). Role of SrtA in Pathogenicity of Staphylococcus lugdunensis. Microorganisms, 8. 10.3390/microorganisms8121975
[8]
Taha "Staphylococcus lugdunensis: Antimicrobial susceptibility and optimal treatment options" Eur. J. Clin. Microbiol. Infect. Dis. (2019) 10.1007/s10096-019-03571-6
[9]
Chowdhury, S., and Fong, S.S. (2020). Computational Modeling of the Human Microbiome. Microorganisms, 8. 10.3390/microorganisms8020197
[10]
Galvani "Improving the prognosis of health care in the USA" Lancet (2020) 10.1016/s0140-6736(19)33019-3
[11]
Papan "Identification and Containment of a Cluster of Two Bacillus cereus Infections in a Neonatal Intensive Care Unit" Can. J. Infect. Dis. Med. Microbiol. (2019) 10.1155/2019/1506583
[12]
Eichel "Update Hygiene: Prevention of Vascular Catheter-Associated Infections in Premature and Newborn Infants" Klinische Padiatrie (2019)
[13]
Papan "A 28-Day-Old Boy with Multifocal Osteomyelitis Mimicking Non-Accidental Injury" Klinische Padiatrie (2021) 10.1055/a-1219-8053
[14]
Escalante "Late Onset Sepsis in Very Low Birth Weight Infants in the South American NEOCOSUR Network" Pediatr. Infect. Dis. J. (2018) 10.1097/inf.0000000000001958
[15]
Wisplinghoff "Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study" Clin. Infect. Dis. (2004) 10.1086/421946
[16]
Rosenthal, V.D., Chaparro, G.J., Servolo-Medeiros, E.A., Souza-Fram, D., Escudero, D., Gualtero-Trujillo, S.M., Morfin-Otero, R., Gonzalez-Diaz, E., Rodriguez-Noriega, E., and Altuzar-Figueroa, M.A. (2021). An eight-year multicenter study on short-term peripheral intravenous catheter-related bloodstream infection rates in 100 intensive care units of 9 countries in Latin America: Argentina, Brazil, Colombia, Costa Rica, Dominican Republic, Ecuador, Mexico, Panama, and Venezuela. Findings of the International Nosocomial Infection Control Consortium (INICC). Infect. Control Hosp. Epidemiol., 1–7. 10.1017/ice.2020.1373
[17]
Ott "The prevalence of nosocomial and community acquired infections in a university hospital: An observational study" Dtsch. Aerzteblatt Int. (2013)
[18]
Noshak "The Role of the Coagulase-negative Staphylococci (CoNS) in Infective Endocarditis; A Narrative Review from 2000 to 2020" Curr Pharm Biotechnol. (2020) 10.2174/1389201021666200423110359
[19]
Kranjec, C., Morales Angeles, D., Torrissen Mårli, M., Fernández, L., García, P., Kjos, M., and Diep, D.B. (2021). Staphylococcal Biofilms: Challenges and Novel Therapeutic Perspectives. Antibiotics, 10. 10.3390/antibiotics10020131
[20]
Ruiz-Ripa, L., Gómez, P., Alonso, C.A., Camacho, M.C., Ramiro, Y., de la Puente, J., Fernández-Fernández, R., Quevedo, M.Á., Blanco, J.M., and Báguena, G. (2020). Frequency and Characterization of Antimicrobial Resistance and Virulence Genes of Coagulase-Negative Staphylococci from Wild Birds in Spain. Detection of tst-Carrying, S. sciuri Isolates. Microorganisms, 8. 10.3390/microorganisms8091317
[21]
(2021, March 01). Servier Medical Art. Available online: https://smart.servier.com.
[22]
Gallert "Staphylococcus argensis sp. nov., a novel staphylococcal species isolated from an aquatic environment" Int. J. Syst. Evol. Microbiol. (2015) 10.1099/ijs.0.000319
[23]
Pantůček, R., Sedláček, I., Indráková, A., Vrbovská, V., Mašlaňová, I., Kovařovic, V., Švec, P., Králová, S., Krištofová, L., and Kekláková, J. (2018). Staphylococcus edaphicus sp. nov., Isolated in Antarctica, Harbors the mecC Gene and Genomic Islands with a Suspected Role in Adaptation to Extreme Environments. Appl. Environ. Microbiol., 84. 10.1128/aem.01746-17
[24]
MacFadyen "Staphylococcus caeli sp. nov., isolated from air sampling in an industrial rabbit holding" Int. J. Syst. Evol. Microbiol. (2019) 10.1099/ijsem.0.003098
[25]
MacFadyen "Staphylococcus pseudoxylosus sp. nov., isolated from bovine mastitis" Int. J. Syst. Evol. Microbiol. (2019) 10.1099/ijsem.0.003416
[26]
Naushad "Staphylococcus debuckii sp. nov., a coagulase-negative species from bovine milk" Int. J. Syst. Evol. Microbiol. (2019) 10.1099/ijsem.0.003457
[27]
Westblom "Anaerobic endocarditis caused by Staphylococcus saccharolyticus" J. Clin. Microbiol. (1990) 10.1128/jcm.28.12.2818-2819.1990
[28]
Krishnan "Prosthetic valve endocarditis due to Staphylococcus saccharolyticus" Clin. Infect. Dis. (1996) 10.1093/clinids/22.4.722
[29]
Steinbrueckner "Facing a mysterious hospital outbreak of bacteraemia due to Staphylococcus saccharolyticus" J. Hosp. Infect. (2001) 10.1053/jhin.2001.1105
[30]
Godreuil "Unusual case of spondylodiscitis due to Staphylococcus saccharolyticus" Joint Bone Spine (2005) 10.1016/j.jbspin.2004.08.010
[31]
Mikhael "Multilevel diskitis and vertebral osteomyelitis after diskography" Orthopedics (2009) 10.3928/01477447-20090101-16
[32]
Worlitzsch "Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients" Clin. Microbiol. Infect. (2009) 10.1111/j.1469-0691.2008.02659.x
[33]
Wu "A case of Staphylococcus saccharolyticus pneumonia" Int. J. Infect. Dis. (2009) 10.1016/j.ijid.2008.06.007
[34]
Ali "Strict anaerobic Staphylococcus saccharolyticus isolates recovered from contaminated platelet concentrates fail to multiply during platelet storage" Transfusion (2012) 10.1111/j.1537-2995.2011.03510.x
[35]
Schneeberger "Injection-induced low-grade infection of the shoulder joint: Preliminary results" Arch. Orthop. Trauma Surg. (2012) 10.1007/s00402-012-1562-z
[36]
Liu "A case of bone marrow infection by Staphylococcus saccharolyticus" Eur. Rev. Med. Pharmacol. Sci. (2015)
[37]
Young "Bilateral Neck Pyomyositis Caused by Staphylococcus capitis and Staphylococcus saccharolyticus in a Diabetic Adult" Case Rep. Infect. Dis. (2017)
[38]
Poehlein "Staphylococcus saccharolyticus Isolated From Blood Cultures and Prosthetic Joint Infections Exhibits Excessive Genome Decay" Front. Microbiol. (2019) 10.3389/fmicb.2019.00478
[39]
Oberbach, A., Friedrich, M., Lehmann, S., Schlichting, N., Kullnick, Y., Gräber, S., Buschmann, T., Hagl, C., Bagaev, E., and Gruhle, M. (2019). Bacterial infiltration in structural heart valve disease. J. Thorac Cardiovasc. Surg. 10.1055/s-0038-1627915
[40]
Ahle, C.M., Stødkilde, K., Afshar, M., Poehlein, A., Ogilvie, L.A., Söderquist, B., Hüpeden, J., and Brüggemann, H. (2020). Staphylococcus saccharolyticus: An Overlooked Human Skin Colonizer. Microorganisms, 8. 10.3390/microorganisms8081105
[41]
Trojani, M.C., Lamy, B., Ruimy, R., Amoretti, N., Risso, K., and Roux, C. (2020). An unusual Staphylococcus saccharolyticus spondylodiscitis post kyphoplasty: A case report. BMC Infect. Dis., 20. 10.1186/s12879-020-05263-5
[42]
Wang "Staphylococcus saccharolyticus infection: Case series with a PRISMA-compliant systemic review" Medicine (2020) 10.1097/md.0000000000020686
[43]
Raoult "Staphylococcus massiliensis sp. nov., isolated from a human brain abscess" Int. J. Syst. Evol. Microbiol. (2010) 10.1099/ijs.0.006486-0
[44]
Dajcs "Staphylococcus petrasii sp. nov. including S. petrasii subsp. petrasii subsp. nov. and S. petrasii subsp. croceilyticus subsp. nov., isolated from human clinical specimens and human ear infections" Syst. Appl. Microbiol. (2013) 10.1016/j.syapm.2012.11.004
[45]
Taylor, S.P., Anderson, W.E., Beam, K., Taylor, B., Ellerman, J., and Kowalkowski, M.A. (2021). The Association Between Antibiotic Delay Intervals and Hospital Mortality Among Patients Treated in the Emergency Department for Suspected Sepsis. Crit. Care Med. 10.1097/ccm.0000000000004863
[46]
Papan, C., Willersinn, M., Weiß, C., Karremann, M., Schroten, H., and Tenenbaum, T. (2020). Antibiotic utilization in hospitalized children under 2 years of age with influenza or respiratory syncytial virus infection—A comparative, retrospective analysis. BMC Infect. Dis., 20. 10.1186/s12879-020-05336-5
[47]
Meyer "A global health perspective on SARS-CoV-2-hazards, disaster and hope" Wien Med. Wochenschr. (2020) 10.1007/s10354-020-00769-8
[48]
Troncoso, C., Pavez, M., Cerda, A., Oporto, M., Villarroel, D., Hofmann, E., Rios, E., Sierralta, A., Copelli, L., and Barrientos, L. (2020). MALDI-TOF MS and 16S RNA Identification of Culturable Gastric Microbiota: Variability Associated with the Presence of Helicobacter pylori. Microorganisms, 8. 10.3390/microorganisms8111763
[49]
Sy, I., Margardt, L., Ngbede, E.O., Adah, M.I., Yusuf, S.T., Keiser, J., Rehner, J., Utzinger, J., Poppert, S., and Becker, S.L. (2020). Identification of Adult Fasciola spp. Using Matrix-Assisted Laser/Desorption Ionization Time-of-Flight (MALDI-TOF) Mass Spectrometry. Microorganisms, 9. 10.3390/microorganisms9010082
[50]
Chiu, K.H.Y., Lam, R.P.K., Chan, E., Lau, S.K.P., and Woo, P.C.Y. (2020). Emergence of Staphylococcus lugdunensis as a Cause of Urinary Tract Infection: Results of the Routine Use of MALDI-TOF MS. Microorganisms, 8. 10.3390/microorganisms8030381

Showing 50 of 99 references

Metrics
118
Citations
99
References
Details
Published
Apr 14, 2021
Vol/Issue
9(4)
Pages
830
License
View
Cite This Article
Ricarda Michels, Katharina Last, Sören L. Becker, et al. (2021). Update on Coagulase-Negative Staphylococci—What the Clinician Should Know. Microorganisms, 9(4), 830. https://doi.org/10.3390/microorganisms9040830
Related

You May Also Like